SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-03-019170
Filing Date
2003-08-19
Accepted
2003-08-19 17:13:45
Documents
11
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a03-2660_210q.htm 10-Q 1035134
3 EX-10.139 a03-2660_2ex10d139.htm EX-10.139 27797
4 EX-10.140 a03-2660_2ex10d140.htm EX-10.140 23860
5 EX-10.141 a03-2660_2ex10d141.htm EX-10.141 18842
6 EX-10.142 a03-2660_2ex10d142.htm EX-10.142 246697
7 EX-10.143 a03-2660_2ex10d143.htm EX-10.143 74231
8 EX-10.144 a03-2660_2ex10d144.htm EX-10.144 75677
9 EX-31.1 a03-2660_2ex31d1.htm EX-31.1 9278
10 EX-31.2 a03-2660_2ex31d2.htm EX-31.2 8250
11 EX-32.1 a03-2660_2ex32d1.htm EX-32.1 5041
12 EX-32.2 a03-2660_2ex32d2.htm EX-32.2 5174
  Complete submission text file 0001104659-03-019170.txt   1532653
Mailing Address 5931 DARWIN COURT CARLSBAD CA 92008
Business Address 5931 DARWIN COURT CARLSBAD CA 92008 7604317080
IMMUNE RESPONSE CORP (Filer) CIK: 0000817785 (see all company filings)

IRS No.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31732 | Film No.: 03856400
SIC: 2836 Biological Products, (No Diagnostic Substances)